Nebraska Medicine is currently navigating a challenging situation as the University of Nebraska Board of Regents considers a significant $800 million deal that would potentially end its partnership with Clarkson. This deal, which involves Clarkson offering its half of Nebraska Medicine along with associated properties, has sparked opposition from the hospital board. Discussions are ongoing regarding a complete takeover of Nebraska Medicine by the NU Regents, with vocal objections from Nebraska Medicine. In a historic move, Clarkson has resigned its membership in Nebraska Medicine, raising further questions about the future governance structure of the organization. The Board of Regents is poised to address these critical topics in upcoming meetings.